The Fantastic Autoimmune Beasts and Where to Find Them
Hairy, scary, funny looking or pretty cool. The beasts in the Harry Potter universe are quite the diverse bunch with unique abilities and qualities. Just like new digital health tech targeted to fight autoimmune diseases or for the main part: their symptoms. Source: Warner Bros. Framestore The common ground for completely different illnesses like type 1 diabetes, inflammatory bowel disease, rheumatoid arthritis, and multiple sclerosis is an immune system disfunction. Immune cells and mechanisms target the body’s own cells and structures, deconstructing it bit by bit and inducing inflammation. An estimated 24-50 million people in the US alone are living with autoimmune conditions. This already affects their day-to-day life, but scientists suggest people living with chronic conditions could be more susceptible to pathogens like the Corona virus (COVID-19). Reducing symptoms and helping the body to overcome the chronic inflammation is the key to a healthier, safer life. Source: villa-medica.com Old symptoms, new tech There are approximately a hundred different illnesses in this category and since all their underlying biological and molecular mechanisms are quite different, it’s hard to pinpoint only one technology to solve all issues. These different causes and mechanisms result in quite a broad spectrum of symptoms. There are a few that are present in many of the 100 diseases. We focused on digital health technologies to tackle these. ...
This study aimed to assess the prevalence and variables related to perceived stress associated with the COVID-19 pandemic in a sample of Colombian adults using a designed online cross-sectional survey. Adults answered a version of the Perceived Stress Scale (PSS-10) modified for COVID-19 (PSS-10-C), with Cronbach alpha equal to 0.86. In total, 406 individuals aged between 19 and 88 years (M = 43.9; SD = 12.4) agreed to participate in the survey: 61.8% were females, 90.6% had a university degree, 44.1% were health professionals, and 45.7% considered public health policies for preventing the spread of the disease inconsisten...
or NN PMID: 32490915 [PubMed - in process]
Abstract COVID-19 has created enormous challenges for health systems worldwide, with the rapidly growing number of deaths and critical patients with pneumonia requiring ventilatory support. Alternative methods to control the spread of the disease such as social isolation, extreme quarantine measures, and contact tracing have been used around the world. However, these measures may not be totally effective to fight COVID-19, in step with the necessary national preparations to meet the new patient care demands. A wide range of digital technologies can be used to enhance these public health strategies, and the pandemi...
CONCLUSIONS: Simultaneous CRC and CRLM resections seem to be safe when patients are carefully selected, also considering the risk of recurrence concerning oncologic outcomes. The pre-planning of simultaneous resection is mandatory to plan trocar positioning, procedure sequencing, and patient position. PMID: 32490901 [PubMed - in process]
Gov. Inslee said Thursday the state is "getting close" to having enough supplies to reach 20,000 tests per day.
Publication date: Available online 3 June 2020Source: Carbohydrate PolymersAuthor(s): Ben Newland, Carmine Varricchio, Yvonne Körner, Franziska Hoppe, Christian Taplan, Heike Newland, Dimitri Eigel, Giusy Tornillo, Dagmar Pette, Andrea Brancale, Petra B. Welzel, F. Philipp Seib, Carsten Werner
Publication date: Available online 3 June 2020Source: Carbohydrate PolymersAuthor(s): Zhuodong Chai, Chao Teng, Lei Yang, Lianjie Ren, Zhongyue Yuan, Siyuan Xu, Manman Cheng, Yanmei Wang, Zhen Yan, Chao Qin, Xiaopeng Han, Lifang Yin
[Premium Times] The Nigeria Centre for Disease Control (NCDC), on Thursday, announced 350 new cases of COVID-19, bringing the total number of confirmed cases in the country to 11,516.
CONCLUSION: a Navigation Program was developed adapted to the Brazilian reality, and attributions of the navigators were created. PMID: 32491120 [PubMed - in process]
Publication date: Available online 3 June 2020Source: Pharmacology Biochemistry and BehaviorAuthor(s): Yasunori Haranishi, Koji Hara, Tadanori Terada
More News: Alopecia | Anemia | Arthritis | Autoimmune Disease | Biotechnology | Brain | Cancer | Cancer & Oncology | Chronic Pain | Coronavirus | COVID-19 | Crohn's Disease | Diabetes | Diabetes Type 1 | e-learning | Eczema | Endocrinology | Hospitals | Inflammatory Bowel Disease | Information Technology | Learning | Molecular Biology | Multiple Sclerosis | Neurology | Pain | Pain Management | Psoriasis | Rheumatoid Arthritis | Rheumatology | Skin | Sleep Disorders | Sleep Medicine | Study | Sugar | Universities & Medical Training | Weight Loss